Abstract:BACKGROUND:Recent advances in sequencing technologies have greatly increased the identification of mutations in cancer genomes. However, it remains a significant challenge to identify cancer-driving mutations, since most observed missense changes are neutral passenger mutations. Various computational methods have been developed to predict the effects of amino acid substitutions on protein function and classify mutations as deleterious or benign. These include approaches that rely on evolutionary conservation, structural constraints, or physicochemical attributes of amino acid substitutions. Here we review existing methods and further examine eight tools: SIFT, PolyPhen2, Condel, CHASM, mCluster, logRE, SNAP, and MutationAssessor, with respect to their coverage, accuracy, availability and dependence on other tools.RESULTS:Single nucleotide polymorphisms with high minor allele frequencies were used as a negative (neutral) set for testing, and recurrent mutations from the COSMIC database as well as novel recurrent somatic mutations identified in very recent cancer studies were used as positive (non-neutral) sets. Conservation-based methods generally had moderately high accuracy in distinguishing neutral from deleterious mutations, whereas the performance of machine learning based predictors with comprehensive feature spaces varied between assessments using different positive sets. MutationAssessor consistently provided the highest accuracies. For certain combinations metapredictors slightly improved the performance of included individual methods, but did not outperform MutationAssessor as stand-alone tool.CONCLUSIONS:Our independent assessment of existing tools reveals various performance disparities. Cancer-trained methods did not improve upon more general predictors. No method or combination of methods exceeds 81% accuracy, indicating there is still significant room for improvement for driver mutation prediction, and perhaps more sophisticated feature integration is needed to develop a more robust tool.

Classification of Mutations by Functional Impact Type: Gain of Function, Loss of Function, and Switch of Function.

HMMvar-func: a New Method for Predicting the Functional Outcome of Genetic Variants

A Comparison on Predicting Functional Impact of Genomic Variants.

Quantitative Prediction of the Effect of Genetic Variation Using Hidden Markov Models

Assessment of Computational Methods for Predicting the Effects of Missense Mutations in Human Cancers.

Predicting loss-of-function impact of genetic mutations: a machine learning approach

Classification of genetic variants using machine learning

Predicting non-neutral missense mutations and their biochemical consequences using genome-scale homology modeling of human protein complexes

Variant effect predictors: a systematic review and practical guide

Bi-Directional Sift Predicts A Subset Of Activating Mutations

Functional categorization of gene regulatory variants that cause Mendelian conditions

DVA: Predicting the Functional Impact of Single Nucleotide Missense Variants

Functional characterization of all missense variants and comparison to in silico models of pathogenicity

Inferring the Functional Effects of Mutation Through Clusters of Mutations in Homologous Proteins.

Improved Detection of Rare Genetic Variants for Diseases

Computational Approaches for Predicting Causal Missense Mutations in Cancer Genome Projects

Assessment of variant effect predictors unveils variants difficulty as a critical performance indicator

Decoding molecular mechanisms for loss of function variants in the human proteome

Functional And Nonfunctional Mutations Distinguished By Random Recombination Of Homologous Genes

Prediction of Deleterious Nonsynonymous Single-Nucleotide Polymorphism for Human Diseases

Prediction and functional analysis of single nucleotide polymorphisms.